UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China Journal article
Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China[J]. DIABETES THERAPY, 2022, 13(10), 1737-1753.
Authors:  Ruan, Zhen;  Ung, Carolina Oi Lam;  Shen, Yang;  Zhang, Yawen;  Wang, Weihao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:8  IF:2.8/2.9 | Submit date:2022/08/28
China  Cost-effectiveness  Diabetes  Dulaglutide  Semaglutide  
Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer Journal article
Luo, Kaipei, Gao, Yi, Yin, Shaoping, Yao, Yawen, Yu, Hua, Wang, Guangji, Li, Juan. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer[J]. Acta Biomaterialia, 2021, 134, 649-663.
Authors:  Luo, Kaipei;  Gao, Yi;  Yin, Shaoping;  Yao, Yawen;  Yu, Hua; et al.
Favorite | TC[WOS]:39 TC[Scopus]:44  IF:9.4/9.9 | Submit date:2022/05/13
Antimetastasis  Chemo-gene Therapy  Co-delivery And Co-rapid Release  Combinative Antitumor Efficacy  Multifunctional Nanocomplex